Stock Events

ProShares UltraShort Nasdaq Biotechnology -2x Shares 

$14.34
10
-$0.13-0.89% Friday 19:59

Statistics

Day High
14.34
Day Low
-
52W High
25.54
52W Low
14.17
Volume
4,657
Avg. Volume
7,900
Mkt Cap
2.81M
P/E Ratio
0
Dividend Yield
4.28%
Dividend
0.61

Upcoming

25
SEP
Dividend Ex
27
SEP
Dividend Payment
23
DEC
Dividend Ex
28
DEC
Dividend Payment
20
MAR 25
Dividend Ex
27
MAR 25
Dividend Payment
26
JUN 25
Dividend Ex
3
JUL 25
Dividend Payment
20
SEP 25
Dividend Ex
27
SEP 25
Dividend Payment

Dividends

4.28%Dividend Yield
Jul 24
$0.16
Mar 24
$0.16
Dec 23
$0.18
Sep 23
$0.12
Jun 23
$0.02
10Y Growth
N/A
5Y Growth
16.82%
3Y Growth
N/A
1Y Growth
94.45%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BIS. It's not an investment recommendation.
Alphabet
68918
GOOGL
Apple
60554
AAPL
Microsoft
56693
MSFT
Amazon
51850
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Direxion Daily S&P Biotech Bear 3X Shares
LABD
Mkt Cap131.45M
Direxion Daily S&P Biotech Bear 3X Shares, offers 3x inverse exposure to an index of US biotechnology stocks, competing directly with BIS's inverse biotech focus.
ProShares UltraShort MSCI Brazil Capped -2x Shares
BZQ
Mkt Cap9.56M
ProShares UltraShort MSCI Brazil Capped, offers -2x exposure to Brazilian stocks, including biotech, competing in the inverse ETF space.
ProShares UltraShort QQQ -2x Shares
QID
Mkt Cap253.78M
ProShares UltraShort QQQ, offers -2x exposure to the NASDAQ-100 Index, competing by targeting a similar index but broader than just biotech.
ProShares UltraPro Short QQQ -3x Shares
SQQQ
Mkt Cap2.68B
ProShares UltraPro Short QQQ, offers -3x exposure to the NASDAQ-100, directly competing in the inverse market with a focus on tech, including biotech.
Direxion Daily S&P Biotech Bull 3X Shares
LABU
Mkt Cap1.13B
Direxion Daily S&P Biotech Bull 3X Shares, the bullish counterpart to LABD, competes by offering the opposite investment strategy in the same sector.
VanEck Biotech
BBH
Mkt Cap451.97M
VanEck Vectors Biotech ETF, offers exposure to biotech stocks, competing as a non-leveraged alternative in the biotech investment space.
iShares Biotechnology
IBB
Mkt Cap7.63B
iShares Biotechnology ETF, provides exposure to a similar biotech index, competing as a more traditional, non-leveraged investment option.
SPDR Biotech
XBI
Mkt Cap7.45B
SPDR S&P Biotech ETF, competes by offering exposure to the biotech sector in a non-leveraged format, appealing to a different risk profile.
ALPS Medical Breakthroughs
SBIO
Mkt Cap112.89M
ALPS Medical Breakthroughs ETF, competes by focusing on small- to mid-cap biotechnology and medical research companies, offering a different take on the biotech sector.

About

Miscellaneous
Investment Trusts/Mutual Funds
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
Show more...
CEO
Country
US
ISIN
US74347G8380

Listings

XNAS
US
BIS